These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19106107)

  • 1. Deoxygenated disaccharide analogs as specific inhibitors of beta1-4-galactosyltransferase 1 and selectin-mediated tumor metastasis.
    Brown JR; Yang F; Sinha A; Ramakrishnan B; Tor Y; Qasba PK; Esko JD
    J Biol Chem; 2009 Feb; 284(8):4952-9. PubMed ID: 19106107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells.
    Fuster MM; Brown JR; Wang L; Esko JD
    Cancer Res; 2003 Jun; 63(11):2775-81. PubMed ID: 12782582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys.
    Brown JR; Fuster MM; Whisenant T; Esko JD
    J Biol Chem; 2003 Jun; 278(26):23352-9. PubMed ID: 12686549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A disaccharide-based inhibitor of glycosylation attenuates metastatic tumor cell dissemination.
    Brown JR; Fuster MM; Li R; Varki N; Glass CA; Esko JD
    Clin Cancer Res; 2006 May; 12(9):2894-901. PubMed ID: 16675586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fucosylation of disaccharide precursors of sialyl LewisX inhibit selectin-mediated cell adhesion.
    Sarkar AK; Rostand KS; Jain RK; Matta KL; Esko JD
    J Biol Chem; 1997 Oct; 272(41):25608-16. PubMed ID: 9325281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UDP-Gal: GlcNAc-R beta1,4-galactosyltransferase--a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme.
    Brockhausen I; Benn M; Bhat S; Marone S; Riley JG; Montoya-Peleaz P; Vlahakis JZ; Paulsen H; Schutzbach JS; Szarek WA
    Glycoconj J; 2006 Nov; 23(7-8):525-41. PubMed ID: 17006644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligosaccharide preferences of beta1,4-galactosyltransferase-I: crystal structures of Met340His mutant of human beta1,4-galactosyltransferase-I with a pentasaccharide and trisaccharides of the N-glycan moiety.
    Ramasamy V; Ramakrishnan B; Boeggeman E; Ratner DM; Seeberger PH; Qasba PK
    J Mol Biol; 2005 Oct; 353(1):53-67. PubMed ID: 16157350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of L- and P-selectin by a rationally synthesized novel core 2-like branched structure containing GalNAc-Lewisx and Neu5Acalpha2-3Galbeta1-3GalNAc sequences.
    Jain RK; Piskorz CF; Huang BG; Locke RD; Han HL; Koenig A; Varki A; Matta KL
    Glycobiology; 1998 Jul; 8(7):707-17. PubMed ID: 9621111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel disaccharide inhibitors for the bacterial galactosyltransferase LgtC: Design, synthesis via Heyns rearrangement, and biochemical evaluation.
    Métier CC; Wagner GK
    Carbohydr Res; 2020 Jun; 492():108017. PubMed ID: 32402851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptor substrate specificity of UDP-Gal: GlcNAc-R beta1,3-galactosyltransferase (WbbD) from Escherichia coli O7:K1.
    Brockhausen I; Riley JG; Joynt M; Yang X; Szarek WA
    Glycoconj J; 2008 Oct; 25(7):663-73. PubMed ID: 18536883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Gal beta 1-->4GlcNAc beta-O-naphthalenemethanol.
    Sarkar AK; Fritz TA; Taylor WH; Esko JD
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3323-7. PubMed ID: 7724561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta 1,3-Galactosyltransferase beta 3Gal-T5 acts on the GlcNAcbeta 1-->3Galbeta 1-->4GlcNAcbeta 1-->R sugar chains of carcinoembryonic antigen and other N-linked glycoproteins and is down-regulated in colon adenocarcinomas.
    Salvini R; Bardoni A; Valli M; Trinchera M
    J Biol Chem; 2001 Feb; 276(5):3564-73. PubMed ID: 11058588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel monoclonal antibodies to putative selectin carbohydrate ligands that inhibit selectin binding to myeloid cells.
    Zhang K; Chuluyan HE; Hardie D; Shen DC; Larsen R; Issekutz A
    Hybridoma; 1998 Oct; 17(5):445-56. PubMed ID: 9873990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin.
    Beauharnois ME; Lindquist KC; Marathe D; Vanderslice P; Xia J; Matta KL; Neelamegham S
    Biochemistry; 2005 Jul; 44(27):9507-19. PubMed ID: 15996105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of the fucose-specific Pseudomonas aeruginosa lectin, PA-IIL, with mammalian glycoconjugates bearing polyvalent Lewis(a) and ABH blood group glycotopes.
    Wu AM; Wu JH; Singh T; Liu JH; Tsai MS; Gilboa-Garber N
    Biochimie; 2006 Oct; 88(10):1479-92. PubMed ID: 16762477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic inhibition of sialyl-Lewis X biosynthesis by 5-thiofucose remodels the cell surface and impairs selectin-mediated cell adhesion.
    Zandberg WF; Kumarasamy J; Pinto BM; Vocadlo DJ
    J Biol Chem; 2012 Nov; 287(47):40021-30. PubMed ID: 23019334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and enzymatic evaluation of modified acceptors of recombinant blood group A and B glycosyltransferases.
    Mukherjee A; Palcic MM; Hindsgaul O
    Carbohydr Res; 2000 May; 326(1):1-21. PubMed ID: 16001502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific detection of sialyl Lewis X determinant carried on the mucin GlcNAcbeta1-->6GalNAcalpha core structure as a tumor-associated antigen.
    Kumamoto K; Mitsuoka C; Izawa M; Kimura N; Otsubo N; Ishida H; Kiso M; Yamada T; Hirohashi S; Kannagi R
    Biochem Biophys Res Commun; 1998 Jun; 247(2):514-7. PubMed ID: 9642161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 1,4-galactosyltransferase (beta 4GalT)-IV is specific for GlcNAc 6-O-sulfate. Beta 4GalT-IV acts on keratan sulfate-related glycans and a precursor glycan of 6-sulfosialyl-Lewis X.
    Seko A; Dohmae N; Takio K; Yamashita K
    J Biol Chem; 2003 Mar; 278(11):9150-8. PubMed ID: 12511560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended core 1 and core 2 branched O-glycans differentially modulate sialyl Lewis X-type L-selectin ligand activity.
    Mitoma J; Petryniak B; Hiraoka N; Yeh JC; Lowe JB; Fukuda M
    J Biol Chem; 2003 Mar; 278(11):9953-61. PubMed ID: 12529363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.